Tenofovir-associated Fanconi`s syndrome and rickets in a HIV infected girl

• Published in: Revista chilena de pediatria Vol. 88; no. 1; p. 148
• Main Authors: Zúñiga, Marcela, Galindo, Armando, Galaz, María Isabel, Vivanco, Maritza, Romero, Patricio, Balboa, Paulina, Torrejón, Claudia
• Format: Journal Article
• Language: Spanish
• Published: Chile 01-02-2017
• Subjects: Anti-HIV Agents - administration & dosage; Anti-HIV Agents - adverse effects; Child; Fanconi Syndrome - chemically induced; Fanconi Syndrome - diagnosis; Female; HIV Infections - drug therapy; Humans; Rickets - chemically induced; Tenofovir - administration & dosage; Tenofovir - adverse effects
• ISSN: 0717-6228

Tenofovir (TDF) is an inhibitor of reverse transcriptase nucleotide analogue, although it has good tolerability and high anti-retroviral activity, its effect on the kidney has been a concern.
To describe a girl infected with HIV who presented Fanconi syndrome during antiretroviral therapy with TDF.
We describe a HIV-1-infected girl, who after 18 months treatment with TDF presented loss of strength and pain of the lower extremities with functional impairment. Laboratory findings were consistent with Fanconi syndrome. Radiographs showed bilateral hip fracture and wrists. Full recovery of Fanconi syndrome was achieved four months after changing antiretroviral therapy.
TDF-prescribing physicians must be prepared to detect signs and symptoms of renal dysfunction and immediately consider switching to another antiviral drug.